April 20, 2018 / 2:27 PM / 7 months ago

BRIEF-Hemispherx Announces Pricing Of $2.57 Million Registered Direct Offering At A Premium To Market

April 20 (Reuters) - Hemispherx Biopharma Inc:

* HEMISPHERX ANNOUNCES PRICING OF $2.57 MILLION REGISTERED DIRECT OFFERING AT A PREMIUM TO MARKET

* HEMISPHERX BIOPHARMA INC - UNDER TERMS OF PURCHASE AGREEMENT, HEMISPHERX HAS AGREED TO SELL ABOUT 6.6 MILLION SHARES OF ITS COMMON STOCK Source text for Eikon: Further company coverage: (Reporting by Deepak Devalapur)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below